| 1 |
35606353 | GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2-STAT3 axis. | 2022 May 23 |
3 |
| 2 |
33465562 | Temozolomide modulates the expression of miRNAs in colorectal cancer. | 2021 |
1 |
| 3 |
34015321 | EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability. | 2021 Aug 5 |
2 |
| 4 |
34036375 | lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. | 2021 Jul |
4 |
| 5 |
34586728 | Interplay of m6 A and histone modifications contributes to temozolomide resistance in glioblastoma. | 2021 Sep |
2 |
| 6 |
34745848 | The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials. | 2021 |
1 |
| 7 |
32194873 | ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. | 2020 |
1 |
| 8 |
29221202 | EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma. | 2017 Nov 10 |
3 |
| 9 |
25400745 | Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma. | 2014 |
1 |